Cartilage tissue engineering repair method based on stem cells

By employing a stem cell-based cartilage tissue engineering repair method, utilizing intelligent biomaterials and nanotechnology scaffolds, combined with a controlled release system and minimally invasive surgery, the limitations of limited cell sources and poor integration in existing technologies have been overcome, achieving efficient cartilage repair and rapid recovery.

CN118949137APending Publication Date: 2024-11-15SHANDONG FIRST MEDICAL UNIV & SHANDONG ACADEMY OF MEDICAL SCI
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410945465.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-15
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Existing cartilage repair technologies face problems such as limited cell sources, low survival rates, low differentiation efficiency, and poor post-transplant integration, making it difficult for traditional treatment methods to achieve complete functional recovery.

Method used

The cartilage tissue engineering repair method based on stem cells involves extracting stem cells from patients and donors, expanding and initially differentiating them in vitro, using smart biomaterials and nanotechnology scaffolds, combined with a controlled release system and minimally invasive surgery for precise positioning and implantation, and promoting repair through rehabilitation training and drug support.

Benefits of technology

It significantly improved the survival rate and differentiation efficiency of stem cells, enhanced tissue integration, reduced immune rejection and surgical trauma, shortened recovery time, and improved the repair effect of cartilage tissue and the quality of life of patients.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118949137A_ABST
    Figure CN118949137A_ABST
Patent Text Reader

Abstract

According to the cartilage tissue engineering repair method based on the stem cells, the stem cells are extracted from a patient and a donor, immunological rejection is reduced, and the transplantation success rate is increased; in-vitro amplification and preliminary differentiation of stem cells are carried out under a specific culture medium condition, so that the cells are ensured to reach an optimal state before transplantation, and the repair effect is enhanced; intelligent biological materials such as temperature-sensitive hydrogel or pH-sensitive polymer are selected, so that excellent biocompatibility and controllability are provided; nano-particles and nano-fibers are introduced into the scaffold, so that the mechanical property and the biological activity of the material are improved; growth factors and drugs are gradually released by utilizing a controllable release system, continuous biological stimulation is provided, and tissue repair is promoted; accurate positioning and implantation are carried out through minimally invasive surgery and arthroscopic technology, surgical wounds are reduced, and postoperative recovery is accelerated; through proper rehabilitation training and medicine support after operation, the joint function is maintained, and inflammatory response is reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biomedical engineering, and more specifically, to a cartilage tissue engineering repair method based on stem cells. Background Art

[0002] Cartilage tissue plays an important role in cushioning and lubricating human joints, but due to its lack of blood supply, once damaged, its self-repair ability is extremely limited. Cartilage injuries are common in various sports injuries, degenerative diseases, and accidents in daily life. Although traditional treatments such as drug therapy, physical therapy, arthroscopic surgery, and cartilage transplantation have certain therapeutic effects, they often cannot completely restore the functional structure of cartilage and have many limitations.

[0003] At present, the development of stem cell technology has brought new hope for cartilage tissue repair. Stem cells have the potential for self-renewal and multidirectional differentiation, and can differentiate into chondrocytes under appropriate conditions, thereby being used for cartilage regeneration and repair. However, stem cell therapy still faces many challenges in practical applications, such as low cell survival rate, low differentiation efficiency, and poor cell integration after transplantation.

[0004] Existing cartilage repair technologies face many challenges, including limited cell sources, low cell survival rate after transplantation, and poor integration of the transplanted site. In particular, the regenerative capacity of cartilage tissue itself is extremely limited, making it difficult for traditional treatments to achieve complete functional recovery. Although existing technologies have made certain progress in cartilage tissue repair, there is still a need to further improve the survival rate and functional differentiation efficiency of stem cells and optimize the tissue integration of transplanted cells.

[0005] Therefore, in view of the above technical problems, it is necessary to provide a cartilage tissue engineering repair method based on stem cells. Summary of the invention

[0006] The purpose of the present invention is to provide a cartilage tissue engineering repair method based on stem cells to solve the above problems.

[0007] In order to achieve the above purpose, the technical solution provided by an embodiment of the present invention is as follows:

[0008] A stem cell-based cartilage tissue engineering repair method comprises the following steps:

[0009] S1. Extract stem cells from the patient and donor;

[0010] S2. In vitro expansion and preliminary differentiation of stem cells under specific culture medium conditions;

[0011] S3. Select and prepare smart biomaterials suitable for cartilage tissue engineering;

[0012] S4, introducing nanoparticles and nanofibers into the scaffold;

[0013] S5, inoculating the pre-cultured stem cells onto the smart scaffold material to form a cell-scaffold complex;

[0014] S6. Cultivate in vitro for a period of time to allow the stem cells to attach, grow and differentiate on the scaffold;

[0015] S7, using the controlled release system in the stent to gradually release growth factors and drugs;

[0016] S8, transplanting the cell-scaffold complex cultured in vitro into the cartilage defect site of the patient;

[0017] S9, precise positioning and implantation through minimally invasive surgery and arthroscopic techniques;

[0018] S10. After transplantation, appropriate rehabilitation training and medication support;

[0019] This method comprehensively utilizes stem cells and intelligent biomaterials to effectively promote the repair and regeneration of cartilage tissue. It has high biocompatibility and mechanical strength, can significantly improve the treatment effect and reduce the patient's pain and recovery time.

[0020] As a further improvement of the present invention, the stem cells in steps S1 and S2 are any one of bone marrow mesenchymal stem cells and induced pluripotent stem cells. Both bone marrow mesenchymal stem cells and induced pluripotent stem cells have good proliferation and differentiation capabilities. Selecting any one of them can be adjusted according to specific needs to provide flexibility.

[0021] As a further improvement of the present invention, the smart biomaterial in step S3 is any one of a temperature-sensitive hydrogel and a pH-sensitive polymer. The temperature-sensitive hydrogel and the pH-sensitive polymer can adjust their physical properties under specific conditions, provide better control and adaptability, and contribute to cell growth and tissue repair.

[0022] As a further improvement of the present invention, the nanoparticles in step S4 include nanosilver particles and nanozinc oxide particles. The nanosilver particles and nanozinc oxide particles have good antibacterial and growth-promoting properties and can improve the biocompatibility and anti-infection ability of the stent material.

[0023] As a further improvement of the present invention, the nanofibers in step S4 are made of polylactic acid-glycolic acid copolymer, collagen and sodium alginate. The nanofibers made of polylactic acid-glycolic acid copolymer, collagen and sodium alginate provide good biocompatibility and mechanical properties, which are conducive to cell attachment and growth.

[0024] As a further improvement of the present invention, the controlled release system in step S7 includes microcapsule and nanocarrier technology, which is used to achieve precise release of growth factors and drugs at a specific time and space. By using microcapsule and nanocarrier technology, the controlled release system can achieve precise release of growth factors and drugs, provide continuous repair support, and promote the repair and regeneration of cartilage tissue.

[0025] As a further improvement of the present invention, the growth factors in step S7 include transforming growth factor β, insulin-like growth factor and bone morphogenetic protein. The introduction of these growth factors can significantly promote the proliferation and differentiation of stem cells, enhance the generation and repair ability of cartilage matrix, and improve the overall effect of cartilage tissue engineering.

[0026] As a further improvement of the present invention, the cell-scaffold complex in step S6 is cultured in vitro for 1 to 4 weeks. By culturing in vitro for 1 to 4 weeks, it is possible to ensure sufficient attachment and initial differentiation of stem cells on the scaffold to form a stable cell-scaffold complex.

[0027] As a further improvement of the present invention, in step S9, minimally invasive surgery and arthroscopic technology are used to accurately position and implant the cell-scaffold complex into the cartilage defect site. By adopting minimally invasive surgery and arthroscopic technology, accurate positioning and implantation of the cell-scaffold complex can be achieved with minimal trauma.

[0028] As a further improvement of the present invention, the rehabilitation training and drug support in step S10 include physical therapy and the use of anti-inflammatory drugs. Rehabilitation training and anti-inflammatory drug support can provide the necessary biological and physical environment for the transplanted cartilage tissue, thereby promoting tissue repair and functional recovery.

[0029] Compared with the prior art, the advantages of the present invention are:

[0030] This program reduces immune rejection and improves the success rate of transplantation by extracting stem cells from the patient and the donor. It also expands and initially differentiates stem cells in vitro under specific culture medium conditions to ensure that the cells reach the optimal state before transplantation and enhance the repair effect. It selects smart biomaterials such as temperature-sensitive hydrogels or pH-sensitive polymers to provide excellent biocompatibility and controllability. It introduces nanoparticles and nanofibers into the scaffold to improve the mechanical properties and bioactivity of the material. It uses a controlled release system to gradually release growth factors and drugs to provide continuous biostimulation and promote tissue repair. It uses minimally invasive surgery and arthroscopic technology for precise positioning and implantation to reduce surgical trauma and accelerate postoperative recovery. It also uses appropriate rehabilitation training and drug support after surgery to maintain joint function and reduce inflammatory response. BRIEF DESCRIPTION OF THE DRAWINGS

[0031] Figure 1It is a schematic diagram of the steps of the repair method of the present invention. DETAILED DESCRIPTION

[0032] The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention; it is obvious that the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments, and all other embodiments obtained by ordinary technicians in this field based on the embodiments of the present invention without making creative work are within the scope of protection of the present invention.

[0033] Embodiment 1:

[0034] See also Figure 1 , a cartilage tissue engineering repair method based on stem cells, comprising the following steps:

[0035] S1. Extract stem cells from the patient and donor;

[0036] S2. In vitro expansion and preliminary differentiation of stem cells under specific culture medium conditions;

[0037] S3. Select and prepare smart biomaterials suitable for cartilage tissue engineering;

[0038] S4, introducing nanoparticles and nanofibers into the scaffold;

[0039] S5, inoculating the pre-cultured stem cells onto the smart scaffold material to form a cell-scaffold complex;

[0040] S6. Cultivate in vitro for a period of time to allow the stem cells to attach, grow and differentiate on the scaffold;

[0041] S7, using the controlled release system in the stent to gradually release growth factors and drugs;

[0042] S8, transplanting the cell-scaffold complex cultured in vitro into the cartilage defect site of the patient;

[0043] S9, precise positioning and implantation through minimally invasive surgery and arthroscopic techniques;

[0044] S10. After transplantation, appropriate rehabilitation training and medication support;

[0045] This method provides a diverse source of stem cells, reduces immune rejection and improves the success rate of transplantation; ensures that the cells reach the optimal state before transplantation through in vitro expansion and preliminary differentiation; uses smart biomaterials to optimize the interaction between materials and cells; introduces nanotechnology to enhance the mechanical properties and bioactivity of materials; uses a controlled release system to provide continuous biostimulation; achieves precise positioning and implantation through minimally invasive surgery and arthroscopic technology, reduces surgical trauma and speeds up postoperative recovery; combines rehabilitation training and drug support to maintain joint function and reduce inflammatory response, which significantly improves the effect of cartilage tissue repair and the quality of life of patients overall.

[0046] The stem cells in steps S1 and S2 are any one of bone marrow mesenchymal stem cells and induced pluripotent stem cells. By using bone marrow mesenchymal stem cells or induced pluripotent stem cells, the most suitable stem cell type can be selected according to the specific situation, the efficiency of cell proliferation and differentiation can be improved, and the tissue repair effect can be enhanced.

[0047] In step S3, the smart biomaterial is any one of a temperature-sensitive hydrogel and a pH-sensitive polymer. By using temperature-sensitive hydrogels and pH-sensitive polymers as smart biomaterials, precise control of cell and drug release can be achieved, and the biocompatibility and mechanical properties during tissue repair can be enhanced.

[0048] The nanoparticles in step S4 include nanosilver particles and nanozinc oxide particles. The nanosilver particles and nanozinc oxide particles have excellent antibacterial and anti-inflammatory properties, can effectively prevent infection and promote tissue healing, and improve the functionality of the scaffold material.

[0049] In step S4, the nanofibers are made of polylactic acid-glycolic acid copolymer, collagen and sodium alginate. The nanofibers made of polylactic acid-glycolic acid copolymer, collagen and sodium alginate can provide good biocompatibility and mechanical strength, help cell attachment and growth, and promote tissue repair.

[0050] The controlled release system in step S7 includes microcapsule and nanocarrier technology, which is used to achieve the precise release of growth factors and drugs at a specific time and space. By adopting microcapsule and nanocarrier technology, the controlled release system can achieve the precise release of growth factors and drugs, provide continuous repair support, and promote the repair and regeneration of cartilage tissue.

[0051] The growth factors in step S7 include transforming growth factor β, insulin-like growth factor and bone morphogenetic protein. Transforming growth factor β, insulin-like growth factor and bone morphogenetic protein are existing growth factors that play a key role in cartilage tissue repair. The introduction of these growth factors can significantly promote the proliferation and differentiation of stem cells, enhance the generation and repair capacity of cartilage matrix, and improve the overall effect of cartilage tissue engineering.

[0052] In step S6, the cell-scaffold complex is cultured in vitro for 1 to 4 weeks. By culturing in vitro for 1 to 4 weeks, it is possible to ensure that the stem cells are fully attached to the scaffold and initially differentiated to form a stable cell-scaffold complex. This culture period can optimize cell growth and functional expression, providing a solid foundation for subsequent in vivo transplantation, thereby improving the transplantation success rate and repair effect.

[0053] In step S9, minimally invasive surgery and arthroscopic techniques are used to accurately position and implant the cell-scaffold complex into the cartilage defect site. By using minimally invasive surgery and arthroscopic techniques, the cell-scaffold complex can be accurately positioned and implanted with minimal trauma. This method reduces surgical trauma and postoperative complications, shortens recovery time, and through precise positioning and implantation, improves the fusion effect of the cell-scaffold complex with surrounding tissues, thereby enhancing the repair efficiency.

[0054] The rehabilitation training and drug support in step S10 include physical therapy and the use of anti-inflammatory drugs. Rehabilitation training and anti-inflammatory drug support can provide the necessary biological and physical environment for the transplanted cartilage tissue, promote tissue repair and functional recovery, physical therapy helps maintain joint mobility and function, and anti-inflammatory drugs can reduce the inflammatory response, promote a faster healing process, and further improve the long-term effect of cartilage repair.

[0055] It can be seen from the above technical solutions that the present invention has the following beneficial effects:

[0056] The present invention reduces immune rejection and improves the success rate of transplantation by extracting stem cells from the patient himself and the donor; performs in vitro amplification and preliminary differentiation of stem cells under specific culture medium conditions to ensure that the cells reach the optimal state before transplantation and enhance the repair effect; selects intelligent biomaterials such as temperature-sensitive hydrogels or pH-sensitive polymers to provide excellent biocompatibility and controllability; introduces nanoparticles and nanofibers into the scaffold to improve the mechanical properties and bioactivity of the material; utilizes a controlled release system to gradually release growth factors and drugs to provide continuous biostimulation and promote tissue repair; performs precise positioning and implantation through minimally invasive surgery and arthroscopic technology to reduce surgical trauma and accelerate postoperative recovery; maintains joint function and reduces inflammatory response through appropriate rehabilitation training and drug support after surgery.

[0057] It will be apparent to those skilled in the art that the invention is not limited to the details of the exemplary embodiments described above and that the invention can be implemented in other specific forms without departing from the spirit or essential features of the invention. Therefore, the embodiments should be considered exemplary and non-limiting in all respects, and the scope of the invention is defined by the appended claims rather than the foregoing description, and it is intended that all variations falling within the meaning and scope of the equivalent elements of the claims be included in the invention. Any reference numeral in a claim should not be considered as limiting the claim to which it relates.

[0058] In addition, it should be understood that although the present specification is described according to embodiments, not every embodiment contains only one independent technical solution. This narrative method of the specification is only for the sake of clarity. Those skilled in the art should regard the specification as a whole. The technical solutions in each embodiment may also be appropriately combined to form other implementation methods that those skilled in the art can understand.

Claims

1. A method for cartilage tissue engineering repair based on stem cells, characterized in that: The following steps are involved: S1. Extract stem cells from the patient and donor; S2. In vitro expansion and preliminary differentiation of stem cells under specific culture medium conditions; S3. Select and prepare smart biomaterials suitable for cartilage tissue engineering; S4, introducing nanoparticles and nanofibers into the scaffold; S5, inoculating the pre-cultured stem cells onto the smart scaffold material to form a cell-scaffold complex; S6. Cultivate in vitro for a period of time to allow the stem cells to attach, grow and differentiate on the scaffold; S7, using the controlled release system in the stent to gradually release growth factors and drugs; S8, transplanting the cell-scaffold complex cultured in vitro into the cartilage defect site of the patient; S9, precise positioning and implantation through minimally invasive surgery and arthroscopic techniques; S10. After transplantation, appropriate rehabilitation training and drug support are provided.

2. The method for cartilage tissue engineering repair based on stem cells according to claim 1, characterized in that: The stem cells in steps S1 and S2 are any one of bone marrow mesenchymal stem cells and induced pluripotent stem cells.

3. The method for cartilage tissue engineering repair based on stem cells according to claim 1, characterized in that: In step S3, the smart biomaterial is any one of a temperature-sensitive hydrogel and a pH-sensitive polymer.

4. The method for cartilage tissue engineering repair based on stem cells according to claim 1, characterized in that: The nanoparticles in step S4 include nanosilver particles and nanozinc oxide particles.

5. The method for cartilage tissue engineering repair based on stem cells according to claim 1, characterized in that: In step S4, the nanofibers are made of polylactic acid-glycolic acid copolymer, collagen and sodium alginate.

6. The method for cartilage tissue engineering repair based on stem cells according to claim 1, characterized in that: The controlled release system in step S7 includes microcapsule and nanocarrier technology, which is used to achieve precise release of growth factors and drugs at a specific time and space.

7. The method for cartilage tissue engineering repair based on stem cells according to claim 1, characterized in that: The growth factors in step S7 include transforming growth factor β, insulin-like growth factor and bone morphogenetic protein.

8. The method for cartilage tissue engineering repair based on stem cells according to claim 1, characterized in that: In step S6, the cell-scaffold complex is cultured in vitro for 1 to 4 weeks.

9. The method for cartilage tissue engineering repair based on stem cells according to claim 1, characterized in that: In step S9, minimally invasive surgery and arthroscopic techniques are used to precisely position and implant the cell-scaffold complex into the cartilage defect site.

10. The method for cartilage tissue engineering repair based on stem cells according to claim 1, characterized in that: The rehabilitation training and drug support in step S10 include physical therapy and the use of anti-inflammatory drugs.

Citation Information

Cited By

  • Oral soft tissue repair equipment and method based on biological cell scaffold

    CN120036977A